Related Experiment Video
Updated: Jul 16, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
[Differences in the risk factors for clinical benign prostatic hyperplasia between the Mongolian and the Han people]
Yun-bin Wang1, Li-ping Xie, Ya-guang Yuan
1Department of Urology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China. wangyunb@163.com
Insights
Mongolian men with benign prostatic hyperplasia (BPH) show higher rates of alcohol consumption, a protein-rich diet, and intraprostatic inflammation compared to Han men. Smoking also correlates with surgical treatment for BPH in Mongolians.
Area of Science:
- Urology
- Epidemiology
- Men's Health
Background:
- Benign prostatic hyperplasia (BPH) is a common condition affecting aging men.
- Risk factors for BPH can vary significantly across different ethnic populations.
- Understanding these differences is crucial for targeted prevention and treatment strategies.
Purpose of the Study:
- To investigate and define the distinct risk factors associated with clinical benign prostatic hyperplasia (BPH) in Mongolian versus Han populations.
- To identify potential etiological differences that may explain variations in BPH prevalence or severity between these two ethnic groups.
Main Methods:
- A comparative study involving 126 patients (63 Mongolian, 63 Han) diagnosed with BPH.
- Data collection utilized a structured questionnaire focusing on known and potential BPH risk factors.
- Interviews were conducted between January 2003 and June 2005.
Main Results:
- Mongolian patients reported significantly higher intake of alcohol, dairy products, and meat compared to Han patients.
- A greater proportion of Mongolian patients were smokers with moderate to severe BPH symptoms (IPSS > 7).
- Higher incidences of intraprostatic chronic inflammation and prostatic calcification were observed in the Mongolian group.
Conclusions:
- Mongolian BPH patients exhibit a distinct risk factor profile, including greater alcohol consumption, a higher protein diet, and increased intraprostatic inflammation compared to Han patients.
- Smoking (smoking index >300) was identified as a factor more likely to lead to surgical intervention in Mongolian BPH patients.
- These findings highlight ethnic-specific risk factors for BPH, suggesting potential differences in disease pathogenesis or environmental influences.
Objective:
To define the differences in the risk factors for clinical benign prostatic hyperplasia (BPH) between the Mongolian and the Han people.
Methods:
Between January 2003 and June 2005, 63 Mongolian and 63 Han patients with BPH were interviewed using a questionnaire consisting of the risk factors for BPH.
Results:
The intake of alcohol and dairy products was higher in the Mongolians than in the Hans (P <0.05). The consumption of milk tea, dairy products and meat was significantly greater in the Mongolians ( >250 g per day) than in the Hans (P <0.01). And there were more smokers (the smoking index >300) with moderate to severe symptoms (IPSS > 7) in the Mongolians than in the Hans (85.71% vs 57. 14%, P <0.01). The incidence of intraprostatic chronic inflammation and calcification within the prostate gland was higher in the Mongolians (28% vs 11% , P < 0.05; 36.5% vs 15.87% , P < 0.01, respectively). No significant difference was observed between the two groups in body mass, blood pressure, marriage age, offspring number, physical activity, IPSS score and PSA level.
Conclusion:
Compared with Han BPH patients, the Mongolian BPH patients had greater alcohol intake, higher protein diet and higher incidence of intraprostatic chronic inflammation, and those with the smoking index greater than 300 were more likely to receive surgical treatment.
Related Concept Videos
Amebiasis
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Microbiota of the Urogenital Tract
Principles of Pharmacogenetics: Types of Genetic Variants